{"Q": 1, "answer": "no", "rationale": "The segment states the network has begun scaling up testing but does not use an intensifier or comparative with a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_19848", "batch_size": 200, "batch_pos": 124, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 2, "answer": "no", "rationale": "The segment reports scaling up testing factually without high-potency language.", "method": "llm_batch", "batch_id": "batch_2_20404", "batch_size": 190, "batch_pos": 81, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 3, "answer": "no", "rationale": "'190 sites', '36 states' are scales, but not paired with a moderate verb describing virus impact.", "method": "llm_batch", "batch_id": "batch_3_19352", "batch_size": 200, "batch_pos": 179, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_6352", "batch_size": 200, "batch_pos": 169, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 5, "answer": "no", "rationale": "Reports scaling up testing, no explicit calming cue about current safety.", "method": "llm_batch", "batch_id": "batch_5_18160", "batch_size": 200, "batch_pos": 163, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser (only, just, merely, etc.) combined with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_3188", "batch_size": 200, "batch_pos": 113, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 7, "answer": "no", "rationale": "No bare negation or explicit calming cue present.", "method": "llm_batch", "batch_id": "batch_7_19564", "batch_size": 194, "batch_pos": 99, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 8, "answer": "yes", "rationale": "Describes scaling up testing, a surveillance/preparedness measure, without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_20240", "batch_size": 161, "batch_pos": 80, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
